v3.26.1
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of stock option activity under all of the Company's equity incentive plans

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Weighted

  ​ ​ ​

Weighted

Average

Shares

Number of

Average

Remaining

Aggregate

Available for

Shares

Exercise

Contractual

Intrinsic

Grant

Outstanding

Price

Life (Years)

Value (000’s)

Available and outstanding as of December 31, 2025

7,275,841

332,676

$

36.10

7.45

$

6

2022 Plan increase

626,525

Granted

 

(3,048,398)

 

3,048,398

 

2.71

 

 

Forfeited

 

95,432

 

(95,432)

 

7.40

 

 

Available and outstanding as of June 30, 2026

4,949,400

3,285,642

$

5.95

9.63

$

Vested and exercisable as of June 30, 2026

 

255,093

$

42.75

 

6.49

$

 

Schedule of assumptions utilized for option grants

  ​ ​ ​

Three Months Ended

  ​ ​ ​

Six Months Ended

June 30, 

June 30, 

2026

  ​ ​ ​

2025

 

2026

  ​ ​ ​

2025

 

Risk-free interest rate

 

4.24

%  

4.03

%

 

4.20

%  

4.11

%

Expected dividend yield

 

%  

%

 

%  

%

Expected volatility

52.28

%  

51.71

%

 

52.28

%  

52.37

%

Expected term (in years)

 

6.1

 

6.1

 

6.1

 

6.1

 

Schedule of stock-based compensation expense recognized in the Company's consolidated statements of operations

  ​ ​ ​

Three Months Ended

  ​ ​ ​

Six Months Ended

June 30, 

June 30, 

2026

  ​ ​ ​

2025

2026

  ​ ​ ​

2025

Cost of revenue

$

37

$

40

$

53

$

86

Research and development

 

86

 

115

 

175

 

263

Sales, general and administrative

 

176

 

230

 

396

 

458

Total

$

299

$

385

$

624

$

807